Impact BioMedical Inc. (NYSEAmerican: IBO) Targeting Chronic Diseases with Patented Breakthroughs
The biotechnology industry is booming, with a global market valued at $1.55 trillion in 2023. Impact BioMedical Inc. (NYSEAmerican: IBO) emerges as a promising player committed to advancing healthcare innovation and targeting chronic diseases with patented breakthroughs.
this news matters because it highlights the significant growth and potential of the biotechnology industry, the urgent need for solutions to chronic inflammatory diseases, and the emergence of Impact BioMedical Inc. as a key player committed to advancing healthcare innovation.
